U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year
The standard Part B premium is rising by about $22 this year, up from $148.50 in 2021 and one of the biggest annual increases ever. About half of that, $11, was attributed to the potential costs of having to cover Aduhelm at its original $56,000 price.
In announcing the price cut just days before the Christmas holidays, Biogen acknowledged the high cost had become a stumbling block to uptake for its medication. A month after approving a controversial new Alzheimer’s drug, the FDA has signed off on new prescribing instructions to limit its use to only patients with early or mild cases of the disease. The acting head of the FDA, Dr. Janet Woodcock, also announced that she was ordering an investigation into whether the agency acted improperly in approving the medication.
Usually the financial impact of high-cost drugs falls most directly on patients with serious diseases such as cancer, rheumatoid arthritis or multiple sclerosis. But with Aduhelm, the pain would be spread among Medicare recipients generally, not just Alzheimer’s patients needing the drug.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Covid: Sunderland patient told booster not possible in hospitalSunderland Royal Hospital says it is now organising the booster after the patient's wife complained.
Les mer »
Florida Teachers Given Expired COVID Tests—and Told to Keep Using ThemThe county’s teachers union said it was working to resolve the issue and told teachers they can swap their tests for new ones if they are past the 90-day window
Les mer »
'Guess Who's Coming to Dinner' told the story of many families, including mineSidney Poitier's timeless performance keeps the 1967 film about a mixed-race couple relevant today; so does its personal resonance for so many.
Les mer »
U.S. stock futures drift lower as Goldman ups Fed rate-hike forecastU.S. stock futures drifted lower Monday, as worries about Federal Reserve policy reverberated, on the technology sector in particular.
Les mer »
Three Fed rate hikes won't be enough to combat inflation, former White House economist saysFormer Council of Economic Advisers Acting Chairman Tyler Goodspeed argues the Federal Reserve is 'so far behind the curve' that three interest rate hikes won't be enough to combat inflation.
Les mer »